Skip to main content
. 2020 May 13;20:222. doi: 10.1186/s12872-020-01505-1

Table 1.

Clinical and Basic Characteristics in the general study populations

CAS Normal Z-value x2-value P-value
N 266 464
Age(y) 53(48,62) 48(42,53) −8.761 <0.001*
Gender 0.000 0.997
male(n,%) 188(70.7) 328(70.7)
female(n,%) 78(29.3) 136(29.3)
Hypertension(n,%) 138(51.9) 149(32.1) 27.691 <0.001#
Diabetes(n,%) 52(19.5) 54(11.6) 8.525 0.004#
Smoking(n,%) 99(37.2) 184(39.7) 0.423 0.515
BMI (kg/m2) 24.76(22.51,26.48) 24.80(22.31,27.05) −0.549 0.583
SBP (mmHg) 133(120,147) 126(114,137) −4.759 <0.001*
DBP (mmHg) 81(73,90) 80(71,87) −2.224 0.026*
hsCRP (mg/L) 1.52(0.73,1.73) 1.45(0.60,1.68) −1.580 0.114
FBG (mmol/L) 5.6(5.1,6.4) 5.3(5.0,5.8) −4.255 <0.001*
TC (mmol/L) 5.10(4.47,5.84) 4.78(4.28,5.46) −3.729 <0.001*
TG (mmol/L) 1.60(1.15,2.40) 1.50(1.11,2.33) −0.839 0.402
LDL (mmol/L) 3.32(2.74,3.92) 3.07(2.64,3.64) −3.485 <0.001*
HDL (mmol/L) 1.34(1.12,1.59) 1.33(1.14,1.56) −0.013 0.990
Hcy (mmol/L) 10.40(8.62,13.50) 9.30(7.70,11.60) −4.713 <0.001*

BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, TG triglycerides, TC total cholesterol, LDL-C low density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, FBG fasting blood glucose, Diabetes: fasting plasma glucose ≥7.0 mmol/L or OGTT 2 h plasma glucose > 11.1 mmol/L, or currently taking antidiabetic drugs

Values are mean ± standard (SD), median (interquartile range, IQR) or percentage

*p<0.05 between cases and controls by Mann-Whitney U-test;#p<0.05 between cases and controls by X2 test